Research News and Research

RSS

Medicaid cuts hurt Miss. Residents, Calif. appeals federal order to reduce prison population amid health concerns

Parents across Mississippi say they are frustrated with state Medicaid officials as programs are downsized and benefits canceled.

30 Nov 2010

NSAID Celebrex may help prevent non-melanoma skin cancer development: Research

New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease.

30 Nov 2010

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). The multi-center, randomized, placebo-controlled, double-blind trial is known as the REVERSE Trial.

30 Nov 2010

Goosby, Emanuel address progress, potential roadblocks ahead for introduction of microbicides in developing countries

The growing evidence supporting the promise of new HIV prevention products, like microbicides, requires that groups start planning now for how best to roll-out prevention interventions in the future, U.S. Global AIDS Coordinator Eric Goosby and Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said Monday during a USAID Microbicide Stakeholders Meeting in Washington.

30 Nov 2010

Celulas Genetica licenses new organ regeneration treatment from Chinese BBFITCL

Emerging Healthcare Solutions, Inc. announced today that its affiliate, Celulas Genetica, purchased a license to develop and market a revolutionary new medical treatment known as the Rutherford Procedure.

30 Nov 2010

California's largest insurers fined nearly $5 million

Los Angeles Times: "California's seven largest health plans were fined nearly $5 million in total Monday for failing to properly pay medical claims submitted by thousands of doctors and hospitals over the last three years. Insurance regulators said the companies also would pay 'tens of millions of dollars' in restitution to medical providers whose claims were underpaid or incorrectly rejected.

30 Nov 2010

Scientists identify signaling pathway and receptor for thymosin beta 4

RegeneRx Biopharmaceuticals, Inc. nnounced that scientists have identified a long sought-after extracellular signaling pathway and receptor for thymosin beta 4 (Tβ4). The observation that Tβ4 increases cell surface ATP (energy produced by cells), could explain its ability to protect and regenerate tissue after ischemic injury and hypoxia (oxygen deficiency).

30 Nov 2010

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

There are some encouraging signs in the epic battle against AIDS and HIV infections. But those bright spots dim considerably in the face of the fact that about 7,100 people a day become infected.

30 Nov 2010

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Inspire Medical Systems, a leading developer of neuro-stimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today that the company has received approval from the U.S. Food and Drug Administration (FDA) to begin its STAR pivotal clinical trial. The STAR trial (Stimulation Therapy for Apnea Reduction), is a multi-center study that will evaluate both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy in patients with moderate to severe obstructive sleep apnea (OSA).

30 Nov 2010

Today's OpEds: Transforming Cal. Safety Net; medical loss ratio; employee health benefits; nurses' role in future

It's time to prepare for the newly insured - and those left behind under reform. Estimates suggest that more than 8 million Californians may be uninsured today, and health care reform, once fully implemented in 2014, may provide coverage for the majority of those currently uninsured.

30 Nov 2010

Are vitamin D and calcium supplements needed?

The IOM raised the recommended dietary allowance of vitamin D from the amount cited in their last report, released 13 years ago. It said that although 600 international units (IUs) of vitamin D or more each day is sufficient to maintain bone health in majority. But those aged 71 and older may need as much as 800 IUs daily, the IOM experts say. However 1997 recommendations advised 400 IUs per day for people aged 51 to 70 and 600 IUs per day for those over 70.

30 Nov 2010

Gavi Alliance elects new chair to continue global immunisation efforts

Former Norwegian Minister of Health and current member of parliament Dagfinn Høybråten was unanimously elected by the GAVI Alliance Board as its new Chair, GAVI announced on the first day of its board meeting taking place in Kigali, the capital of Rwanda.

30 Nov 2010

Evidence of evolutionary protection against inbreeding in women?

Through an innovative use of cell phone records, researchers at UCLA, the University of Miami and Cal State, Fullerton, have found that women appear to avoid contact with their fathers during ovulation.

30 Nov 2010

Neuraltus reports positive results from NP001 Phase 1 study for ALS

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).

30 Nov 2010

Intellikine and MMRC commence INK128 Phase I trial in multiple myeloma

Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.

30 Nov 2010

Kenneth Rainin announces 2011 Innovator Awards Program for Inflammatory Bowel Disease

The Kenneth Rainin Foundation announced today its 2011 Innovator Awards Program for Inflammatory Bowel Disease. The Program, now in its second year, is designed to accelerate the pace of discovery in IBD research.

30 Nov 2010

First Edition: November 30, 2010

Today's headlines include reports on congressional action on the Medicare doc 'pay fix' as well as results from a new poll related to how the public thinks Medicare should be addressed in the context of deficit reduction.

30 Nov 2010

American Journal of Preventive Medicine delineates public health problem about caffeinated alcoholic beverages

In the wake of multiple state bans on caffeinated alcoholic beverages (CABs) and an FDA warning to four companies to remove their products from the marketplace, an article published online today in the American Journal of Preventive Medicine delineates the scope of the public health problem and suggests areas of research that might help address it.

30 Nov 2010

Methodist to develop national training center for treatment of cardiovascular disease

The Methodist DeBakey Heart & Vascular Center recently received a generous gift to develop a national training center for surgical and interventional treatments for cardiovascular disease, the number one killer of Americans. The benefactor wishes to remain anonymous.

30 Nov 2010

Dicom Systems unveils new automated feature of DCMSYS router

San Francisco-based Dicom Systems has unveiled the latest fully automated feature of its DCMSYS router, further improving the effectiveness of its groundbreaking DICOM Systems Router product line, DCMSYS.

30 Nov 2010

Research News and Research

Medicaid cuts hurt Miss. Residents, Calif. appeals federal order to reduce prison population amid health concerns

NSAID Celebrex may help prevent non-melanoma skin cancer development: Research

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

Goosby, Emanuel address progress, potential roadblocks ahead for introduction of microbicides in developing countries

Celulas Genetica licenses new organ regeneration treatment from Chinese BBFITCL

California's largest insurers fined nearly $5 million

Scientists identify signaling pathway and receptor for thymosin beta 4

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Today's OpEds: Transforming Cal. Safety Net; medical loss ratio; employee health benefits; nurses' role in future

Are vitamin D and calcium supplements needed?

Gavi Alliance elects new chair to continue global immunisation efforts

Evidence of evolutionary protection against inbreeding in women?

Neuraltus reports positive results from NP001 Phase 1 study for ALS

Intellikine and MMRC commence INK128 Phase I trial in multiple myeloma

Kenneth Rainin announces 2011 Innovator Awards Program for Inflammatory Bowel Disease

First Edition: November 30, 2010

American Journal of Preventive Medicine delineates public health problem about caffeinated alcoholic beverages

Methodist to develop national training center for treatment of cardiovascular disease

Dicom Systems unveils new automated feature of DCMSYS router

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News